Ganly P S, Jarad N, Rudd R M, Rabbitts P H
Medical Research Council Clinical Oncology and Radiotherapeutics Unit, Medical Research Council Centre, Cambridge, United Kingdom.
Genomics. 1992 Feb;12(2):221-8. doi: 10.1016/0888-7543(92)90369-4.
The tumors of patients with lung cancers often show loss of heterozygosity (LOH) at polymorphic loci on the short arm of chromosome 3. Most examples of small-cell lung carcinoma (SCLC) cannot be examined since they are infrequently resected. Small biopsies are, however, usually available from patients with this disease. We have used the polymerase chain reaction (PCR) to study lung tumor biopsies obtained by fiberoptic bronchoscopy and assign the genotype at 11 RFLPs in 7 well-established loci on 3p. We have demonstrated LOH in some and found that biopsy samples need to contain approximately 60% content of tumor cells if LOH is to be reliably detected. One SCLC tumor that we examined has an interstitial 3p deletion proximal to the locus D3F15S2 and thus provides information useful in mapping the position of the tumor suppressor gene on 3p.
肺癌患者的肿瘤常在3号染色体短臂的多态性位点出现杂合性缺失(LOH)。大多数小细胞肺癌(SCLC)病例因很少接受切除而无法进行检查。不过,对于患有这种疾病的患者,通常可以获得小块活检组织。我们利用聚合酶链反应(PCR)研究了通过纤维支气管镜检查获取的肺肿瘤活检组织,并确定了位于3p上7个已明确位点的11个限制性片段长度多态性(RFLP)的基因型。我们在一些病例中证实了存在LOH,并且发现如果要可靠地检测到LOH,活检样本需要含有大约60%的肿瘤细胞。我们检查的一个SCLC肿瘤在D3F15S2位点近端存在3p间质缺失,因此为定位3p上肿瘤抑制基因的位置提供了有用信息。